Had an awesome time connecting with The Council Angels in NYC this week!

We talked life, startup valuations, transitioning from employee to business owner and vice versa, sales as a founder superpower and more 🥰

Shriya Nevatia Azza A. Gadir, PhD Cindy Berman Cameron Langford halle…

The Genentech/Orionis deal was selected as a finalist in In Vivo's 'Deals of the Year' contest - Please feel free to vote for us☺️ in the 'Top Alliances of 2023' category 🙏 invivo.citeline.com/IV148673/In-Vi…

And Spatial VDJ is out! More to follow, but for now, joy and gratitude for the privilege to work with the wonderful Kim Thrane Qirong Lin Jeffrey Mold Jonas Frisén Joakim Lundeberg and many more collaborators. Karolinska Institutet SciLifeLab KTH Royal Institute of Technology science.org/doi/10.1126/sc…

#LocationLocationLocation ! Miriam Merad, MD, PhD &co show nature that IL-4 produced in the bone marrow 🤯 by basophils & eosinophils transcriptionally acts on granulocyte-monocyte progenitors to drive immunosuppressive myeloid cells that promote lung #tumor growth doi.org/10.1038/s41586…

Going after cancer and combatting undruggable diseases Orionis Biosciences is evolving immunotherapies that will ultimately help so many! I am proud to be a part of this incredible company. Looking forward to supporting the journey. Today is a great milestone and many more to come 👏

Big News! Exciting News! Again😊Very proud to be part of this now, in the past, and in the future! #immunotherapy #cancerresearch

Two important company announcements today!

1: First cancer patient dosed in a Phase 1 immunotherapy clinical trial of ORB-011, a first-in-class targeted interferon A-Kine®.
2: Tony Fadell, Founder and Principal at Build Collective, joins Orionis Board of Directors.

Learn more…

🚨 The Council Angels just opened up applications for our next cohort! Apply below.

Great way to source more deals, improve your diligence process alongside peers, and get direct allocation in awesome companies.

This community is what gave me my start!

Emerging approaches to induce immune tolerance to therapeutic proteins: Trends in Pharmacological Sciences cell.com/trends/pharmac…

Special issue on 'The cancer-immunity cycle,' a concept first introduced by Mellman & Chen in 2013 that provided a framework to understand anti-cancer immunity | Seven articles discussing progress & advances in the field & highlighting key challenges #cancerimmunitycycle …

Very cool to see a second collaboration on Molecular Glue discovery with Orionis Biosciences, here with @roche Genentech. Niko and friends are creative scientists, terrific partners at the bench. Proud to see this platform expand its potential impact. orionisbio.com/2023/09/genent…

Today we announced a collaboration with Genentech to discover and develop molecular glue class medicines using our Allo-Glue™ platform. Learn more: orb.ink/2023_AG

Very exciting that my PhD work on local firms in the Nigerian oil sector has been featured in VoxDev. Take a look here:

One week left to apply! Unlock Her Potential
FREE MENTORSHIP FOR WOMEN OF COLOR

Mentors in Art, C-Suite, Culinary, Film/TV, Journalism, Marketing, Music, Publishing, Social Impact/Advocacy, STEM

unlockherpotential.com

If you prefer your latest science in AI-generated limerick:

In tissues, Tregs were once thought confined,
To one spot, their fate pre-defined.
But their magic's widespread,
Through diverse lands they've tread,
In many tissues, their charm's enshrined!
biorxiv.org/content/10.110…

The immune system is really amazing! Here’s a video of a T cell killing a cancer cell. (Not AI!!)

Credit: Jeroen Slaats

Incredible news.